logo
K92 Mining Announces Strong Q2 Production Results – 34,816 oz AuEq Produced, and Commenced Commissioning of 1.2 Mtpa Stage 3 Process Plant in June

K92 Mining Announces Strong Q2 Production Results – 34,816 oz AuEq Produced, and Commenced Commissioning of 1.2 Mtpa Stage 3 Process Plant in June

VANCOUVER, British Columbia, July 08, 2025 (GLOBE NEWSWIRE) — K92 Mining Inc. ('K92' or the 'Company') (TSX: KNT; OTCQX: KNTNF) is pleased to announce production results for the second quarter ('Q2') of 2025 from its Kainantu Gold Mine in Papua New Guinea.
Q2 2025 Production Results
Stage 3 Expansion – Significant Progress Made. Stage 3 Plant Commissioning Commenced.
Note (1): Gold equivalent production for Q2 2025 is calculated based on: gold $3,299 per ounce; silver $33.41 per ounce; and copper $4.31 per pound. Gold equivalent grade for Q2 incorporates realized recoveries of 93.3% for Au, 94.9% for Cu and 83.7% for Ag.
John Lewins, K92 Chief Executive Officer and Director, stated,
'K92 is on the cusp of transforming into a Tier 1 mid-tier producer, with commissioning of the new 1.2 million tonnes-per-annum Stage 3 Expansion Process Plant now underway. The plant incorporates state-of-the-art processing technologies and remains on schedule for practical completion of commissioning in the first half of Q4 2025.
Underground infrastructure upgrades are also nearing completion, including a fully operational ore/waste pass, Puma ventilation drive, and two large-diameter raisebore ventilation raises — key enablers for higher mining rates. Additionally, the recent commencement of commissioning surface-operated tele-remote loaders marks the first wave of productivity enhancements enabled by our underground communications upgrade.
Importantly, we are also well-advanced on opening up two new mining fronts in the Twin Incline and the Lower Kora, which position the mine for higher throughput and an increase in ore tonnes from lower-cost long-hole stoping. Meanwhile, construction contracts for all major pastefill infrastructure have been awarded, with commissioning expected to commence in mid-Q1 2026.
Overall we are very pleased with our production performance in the first half of 2025, which is ahead of budget. With a stronger second half anticipated, driven by higher throughput in Q4, we reiterate our 2025 production guidance.'
See Figure 1: Quarterly Production, Cash Cost and AISC Chart
See Figure 2: Gold and Copper Recoveries Chart
Table 1 – 2025 & 2024 Annual Production Data
Notes – Gold equivalent for Q2 2025 is calculated based on:
gold $3,299 per ounce; silver $33.41 per ounce; and copper $4.31 per pound.
Gold equivalent for Q1 2025 is calculated based on:
gold $2,855 per ounce; silver $31.73 per ounce; and copper $4.26 per pound
Gold equivalent for Q4 2024 is calculated based on:
gold $2,658 per ounce; silver $31.52 per ounce; and copper $4.25 per pound.
Gold equivalent for Q3 2024 is calculated based on:
gold $2,474 per ounce; silver $29.43 per ounce; and copper $4.17 per pound.
Gold equivalent for Q2 2024 is calculated based on:
gold $2,338 per ounce; silver $28.84 per ounce; and copper $4.42 per pound.
Qualified Person
K92 Mine Chief Geologist, Andrew Kohler, PGeo, a qualified person under the meaning of Canadian National Instrument 43-101 –
Standards of Disclosure for Mineral Projects
, has reviewed and is responsible for the technical content of this news release. Data verification by Mr. Kohler includes significant time onsite reviewing drill core, face sampling, underground workings, and discussing work programs and results with geology and mining personnel.
Technical Report
The Updated DFS and mineral resource estimate for the Kainantu Gold Mine Project in Papua New Guinea is presented in a technical report, titled, 'Independent Technical Report, Kainantu Gold Mine, Updated Definitive Feasibility Study, Kainantu Project, Papua New Guinea' dated March 21, 2025, with an effective date of January 1, 2024.
About K92
K92 Mining Inc. is engaged in the production of gold, copper and silver at the Kainantu Gold Mine in the Eastern Highlands province of Papua New Guinea, as well as exploration and development of mineral deposits in the immediate vicinity of the mine. The Company declared commercial production from Kainantu in February 2018, is in a strong financial position, and is working to become a Tier 1 mid-tier producer through ongoing plant expansions. A maiden resource estimate on the Blue Lake copper-gold porphyry project was completed in August 2022. K92 is operated by a team of mining company professionals with extensive international mine-building and operational experience.
On Behalf of the Company,
John Lewins, Chief Executive Officer and Director
For further information, please contact David Medilek, P.Eng., CFA, President and Chief Operating Officer at +1-604-416-4445
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION:
This news release includes certain 'forward-looking statements' under applicable Canadian securities legislation. Such forward-looking statements include, without limitation: (i) the results of the Kainantu Mine Definitive Feasibility Study, including the Stage 3 Expansion, a new standalone 1.2 million tonnes per annum process plant and supporting infrastructure; (ii) statements regarding the expansion of the mine and development of any of the deposits; (iii) the Kainantu Stage 4 Expansion, operating two standalone process plants, larger surface infrastructure and mining throughputs; and (iv) the potential extended life of the Kainantu Mine.
All statements in this news release that address events or developments that we expect to occur in the future are forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, although not always, identified by words such as 'expect', 'plan', 'anticipate', 'project', 'target', 'potential', 'schedule', 'forecast', 'budget', 'estimate', 'intend' or 'believe' and similar expressions or their negative connotations, or that events or conditions 'will', 'would', 'may', 'could', 'should' or 'might' occur. All such forward-looking statements are based on the opinions and estimates of management as of the date such statements are made. Forward-looking statements are necessarily based on estimates and assumptions that are inherently subject to known and unknown risks, uncertainties and other factors, many of which are beyond our ability to control, that may cause our actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking information. Such factors include, without limitation, Public Health Crises, including the epidemic or pandemic viruses; changes in the price of gold, silver, copper and other metals in the world markets; fluctuations in the price and availability of infrastructure and energy and other commodities; fluctuations in foreign currency exchange rates; volatility in price of our common shares; inherent risks associated with the mining industry, including problems related to weather and climate in remote areas in which certain of the Company's operations are located; failure to achieve production, cost and other estimates; risks and uncertainties associated with exploration and development; uncertainties relating to estimates of mineral resources including uncertainty that mineral resources may never be converted into mineral reserves; the Company's ability to carry on current and future operations, including development and exploration activities at the Arakompa, Kora, Judd and other projects; the timing, extent, duration and economic viability of such operations, including any mineral resources or reserves identified thereby; the accuracy and reliability of estimates, projections, forecasts, studies and assessments; the Company's ability to meet or achieve estimates, projections and forecasts; the availability and cost of inputs; the availability and costs of achieving the Stage 3 Expansion or the Stage 4 Expansion; the ability of the Company to achieve the inputs the price and market for outputs, including gold, silver and copper; failures of information systems or information security threats; political, economic and other risks associated with the Company's foreign operations; geopolitical events and other uncertainties, such as the conflicts in Ukraine, Israel and Palestine; compliance with various laws and regulatory requirements to which the Company is subject to, including taxation; the ability to obtain timely financing on reasonable terms when required; the current and future social, economic and political conditions, including relationship with the communities in Papua New Guinea and other jurisdictions it operates; other assumptions and factors generally associated with the mining industry; and the risks, uncertainties and other factors referred to in the Company's Annual Information Form under the heading 'Risk Factors'.
Estimates of mineral resources are also forward-looking statements because they constitute projections, based on certain estimates and assumptions, regarding the amount of minerals that may be encountered in the future and/or the anticipated economics of production. The estimation of mineral resources and mineral reserves is inherently uncertain and involves subjective judgments about many relevant factors. Mineral resources that are not mineral reserves do not have demonstrated economic viability. The accuracy of any such estimates is a function of the quantity and quality of available data, and of the assumptions made and judgments used in engineering and geological interpretation, Forward-looking statements are not a guarantee of future performance, and actual results and future events could materially differ from those anticipated in such statements. Although we have attempted to identify important factors that could cause actual results to differ materially from those contained in the forward-looking statements, there may be other factors that cause actual results to differ materially from those that are anticipated, estimated, or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Figure 1:
Quarterly Production, Co-Product Cash Cost and Co-Product AISC Chart
Figure 2: Gold and Copper Recoveries Chart
Photos accompanying this announcement are available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/d6c14d70-ca04-4385-a7bc-bae11dc3a7cf
https://www.globenewswire.com/NewsRoom/AttachmentNg/da1bc044-0acb-4f74-bb57-75868fb6fcce
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Coloplast A/S – Interim Financial Report, 9M 2024/25
Coloplast A/S – Interim Financial Report, 9M 2024/25

Business Upturn

time2 hours ago

  • Business Upturn

Coloplast A/S – Interim Financial Report, 9M 2024/25

By GlobeNewswire Published on August 19, 2025, 10:33 IST 2024/25 Interim financial results, 9M 2024/25 1 October 2024 – 30 June 2025 Coloplast delivered organic growth of 7% and an EBIT margin1 of 28% in Q3. Reported revenue in DKK grew 1% with negative impact from currencies and the Skin Care divestment. Organic growth rates by business area: Ostomy Care 6%, Continence Care 8%, Voice and Respiratory Care 9%, Advanced Wound Care 4% and Interventional Urology 4%. Growth in Ostomy Care was driven by broad-based contribution across regions, except for China which delivered low-single digit growth, as expected. Growth in Continence Care was driven by continued strong contribution from the Luja™ portfolio. Voice and Respiratory Care growth was driven by continued good momentum in both Laryngectomy and Tracheostomy. Growth in Advanced Wound Dressings was -2%, driven primarily by a significant decline in China which was impacted by a preventative and voluntary product return of all Biatain® Adhesive foam dressings in the market. The product return is expected to have a negative revenue impact of around DKK 80 million in H2, of which around DKK 20 million impacted Q3. Kerecis grew 17%, with a 13% EBIT margin before PPA amortisation. Growth in the quarter was impacted by a slowdown in the out-patient setting due to the LCD postponement in April, causing a temporary market shift to high-priced products. Growth momentum in Q4 is expected to improve, with a good start to the quarter in July. Growth in Interventional Urology was driven by good momentum in the US Men's Health business, partly offset by continued negative impact from the product recall in Bladder Health and Surgery of around DKK -10 million in Q3. EBIT 1 was DKK 1,915 million, a 2% increase from last year. The EBIT margin 1,2 was 28%, against 27% last year. was DKK 1,915 million, a 2% increase from last year. The EBIT margin was 28%, against 27% last year. Changes to the Executive Leadership Team announced, to support the successful execution of the new company strategy towards 2030. 9M 2024/25 organic growth of 7% and EBIT margin1 of 27%. Reported revenue in DKK grew 4% to DKK 20,914 million. Organic growth rates by business area: Ostomy Care 6%, Continence Care 8%, Voice and Respiratory Care 9%, Advanced Wound Care 9% and Interventional Urology 1%. EBIT 1 was DKK 5,718 million, a 4% increase from last year. The EBIT margin 1 was 27%, on par with last year 2 . was DKK 5,718 million, a 4% increase from last year. The EBIT margin was 27%, on par with last year . Adjusted3 net profit before special items was DKK 3,778 million, a DKK 15 million decrease from last year, negatively impacted by non-cash effect from net financial expenses. Adjusted3 diluted earnings per share (EPS) before special items decreased by 1% to DKK 16.76. Adjusted3 ROIC after tax before special items was 15%, on par with last year. FY 2024/25 guidance is unchanged with organic growth of around 7% and an EBIT margin before special items of 27-28%. Organic growth now includes the negative impact from the product return in Advanced Wound Dressings in China, partly offset by good momentum in the other business areas. Reported growth in DKK is now expected to be 3-4%, with around 2%-points negative impact from currencies and around 1.5%-points negative impact from the Skin Care divestment. The assumptions on the reported EBIT margin before special items are largely unchanged. Special items expectations are unchanged, around DKK 450 million. Expectations on capital expenditures and tax rate (ordinary and effective) are also unchanged. 'We deliver a third quarter as expected with 7% organic growth and an EBIT margin of 28%, maintaining our financial guidance for 2024/25. Our Q3 performance was driven by broad-based growth across our chronic care businesses, offsetting the challenges in China. I'm pleased to see the global Coloplast organisation continuing to deliver on our priorities and moving the business forward. The search for Coloplast's new CEO remains on track. I look forward to presenting our 2030 strategy at our Capital Markets Day on 2 September alongside the new Executive Leadership Team, announced today,' says interim CEO Lars Rasmussen. 1. before special items expenses of DKK 83 million in Q3 2024/25 and DKK 241 million in 9M 2024/25. 2. before special items expenses of DKK 36 million in Q3 2023/24 and DKK 70 million in 9M 2023/24. 3. Adjusted for the impact from the Kerecis IP transfer. Conference call Coloplast will host a conference call on Tuesday, 19 August 2025 at 11.00 CEST. The call is expected to last about one actively participate in the Q&A session please sign up ahead of the conference call on the link here to receive an e-mail with dial-in details: Register here Access the conference call webcast directly here: Coloplast – 9M 2024/25 conference call For further information, please contact Investors and analysts Anders Lonning-SkovgaardExecutive Vice President, CFO Tel. +45 4911 1111 Aleksandra DimovskaVice President, Investor RelationsTel. +45 4911 1800 / +45 4911 2458 Email: [email protected] Kristine Husted MunkSenior Manager, Investor RelationsTel. +45 4911 1800 / +45 4911 3266 Email: [email protected] Simone Dyrby HelvindSenior Manager, Investor RelationsTel. +45 4911 1800 / +45 4911 2981 Email: [email protected] Press and media Peter MønsterSr. Media Relations ManagerTel. +45 4911 2623 Email: [email protected] Address Coloplast A/SHoltedam 1DK-3050 HumlebaekDenmark Company reg. (CVR) no. 69749917 Website This announcement is available in a Danish and an English-language version. In the event of discrepancies, the English version shall prevail. Coloplast was founded on passion, ambition, and commitment. We were born from a nurse's wish to help her sister and the skills of an engineer. Guided by empathy, our mission is to make life easier for people with intimate healthcare needs. Over decades, we have helped millions of people to live a more independent life and we continue to do so through innovative products and services. Globally, our business areas include Ostomy Care, Continence Care, Advanced Wound Care, Interventional Urology and Voice and Respiratory Care. The Coloplast logo is a registered trademark of Coloplast A/S. © 2025-08. All rights reserved Coloplast A/S, 3050 Humlebaek, Denmark. Attachment 06_2025_9M_2024_25_Earnings_release Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.

Navatar Unveils AI-Powered CRM That Meets M&A Advisors Where They Work From Outlook to Slack to CRM: Investment Banking's First Truly Embedded Intelligence Platform For Salesforce
Navatar Unveils AI-Powered CRM That Meets M&A Advisors Where They Work From Outlook to Slack to CRM: Investment Banking's First Truly Embedded Intelligence Platform For Salesforce

Business Upturn

time3 hours ago

  • Business Upturn

Navatar Unveils AI-Powered CRM That Meets M&A Advisors Where They Work From Outlook to Slack to CRM: Investment Banking's First Truly Embedded Intelligence Platform For Salesforce

By GlobeNewswire Published on August 19, 2025, 10:28 IST LONDON and NEW YORK, Aug. 19, 2025 (GLOBE NEWSWIRE) — Navatar, the leading platform for private markets, today announced the launch of its next-generation, fully AI-powered CRM purpose-built for M&A advisory firms. The new platform combines intelligence, automation, and usability—solving one of the biggest challenges firms face when trying to put AI to work: data. A recent Business Insider article warned: 'AI intensifies data flaws rather than solving them,' noting that data is one of the top reasons AI projects fail. For many advisory firms, legacy CRMs have made that problem worse—requiring tedious data entry that bankers inevitably avoid. As a result, most of the useful intelligence remains trapped in inboxes, documents and individual banker memory. Navatar solves this by automatically capturing and structuring activity from emails, call notes, LinkedIn, Slack, documents, public domain and third-party data—including relevant benchmarks, market comps, and triggers from the public internet—turning your team's daily activity into structured, usable intelligence for AI to operate on—turning your team's daily activity into structured, usable intelligence for AI to operate on. AI Where You Work: Inside Outlook, Navatar, or Slack Navatar combines the best of Salesforce AI (Agentforce 3)and Microsoft Copilot so dealmakers no longer need to log into a CRM to get intelligence. Whether working inside Outlook, Navatar or Slack, users receive real-time insights, recommendations, and automation—all natively delivered in the tools they already use. Leveraging Salesforce's Agentforce, Navatar ensures that all proprietary client and deal information remains private and compliant, never shared with or exposed to public AI models. Firms get the power of generative AI with the security of an enterprise-grade, private data environment. Within Microsoft Outlook Smart Contact Insights – See who knows the contact, related mandates, and past interactions directly in your inbox. – See who knows the contact, related mandates, and past interactions directly in your inbox. Email Summarization & Next Steps – AI condenses long threads and suggests follow-ups, tasks, and next steps. – AI condenses long threads and suggests follow-ups, tasks, and next steps. Deal Context at a Glance – View associated mandates, stage, and buyer/seller lists without logging in. – View associated mandates, stage, and buyer/seller lists without logging in. Automated Meeting Prep – Get AI-generated briefs from emails, calendar events, and CRM activity. – Get AI-generated briefs from emails, calendar events, and CRM activity. Activity Capture – Sync emails, calendar and meetings to the right deals and clients automatically. Within Navatar Thematic Sourcing – Identify sectors and companies likely to transact by analyzing market signals, including public news, filings, and web-based benchmarks. – Identify sectors and companies likely to transact by analyzing market signals, including public news, filings, and web-based benchmarks. Buyer/Seller Matching – Predict the most likely matches based on past transactions and strategic fit. – Predict the most likely matches based on past transactions and strategic fit. Relationship Intelligence : Auto-map referral paths, warm intros, and deal team connectivity using AI across your team's network. : Auto-map referral paths, warm intros, and deal team connectivity using AI across your team's network. Document Intelligence – Extract key terms, risks, and data from documents and models. – Extract key terms, risks, and data from documents and models. Pipeline Intelligence – Generate AI summaries for pipeline reporting. – Generate AI summaries for pipeline reporting. Task Automation – Auto-create follow-ups based on conversation or document triggers. Within Slack CRM Alerts in Slack – Get real-time updates on mandates, buyer interest, and client activity. – Get real-time updates on mandates, buyer interest, and client activity. Conversation Linking – Tag Slack threads to deals, clients, or contacts. – Tag Slack threads to deals, clients, or contacts. AI Channel Summaries – Capture highlights and actions from busy deal channels. – Capture highlights and actions from busy deal channels. Push to CRM – Log notes or tasks in Navatar directly from Slack. AI Use Cases for M&A Advisory Firms Navatar's AI transforms every stage of the advisory workflow: Deal Origination – Thematic sourcing, buyer/seller matching, relationship mapping, competitive intelligence. – Thematic sourcing, buyer/seller matching, relationship mapping, competitive intelligence. Pitching – AI-generated buyer lists, pitch deck content, market comps, and tailored sector heatmaps. – AI-generated buyer lists, pitch deck content, market comps, and tailored sector heatmaps. Execution – Document review, data room analysis, call summaries, buyer engagement scoring. – Document review, data room analysis, call summaries, buyer engagement scoring. Client Coverage – Contact enrichment, coverage risk alerts, cross-sell opportunity detection. – Contact enrichment, coverage risk alerts, cross-sell opportunity detection. Market Intelligence – Real-time alerts, comps/multiples tracking, buyer watchlists. – Real-time alerts, comps/multiples tracking, buyer watchlists. Workflow Automation – Automatic activity logging, task creation, and compliance trails. About Navatar Navatar (@navatargroup) powers leading investment banks, M&A advisory firms, and alternative asset managers with cloud CRM solutions purpose-built for private markets. Now fully AI-powered, Navatar captures intelligence automatically and delivers insights directly into Outlook, Slack, and CRM—turning every interaction into firmwide knowledge. Built on Salesforce and integrated with Microsoft Copilot, Navatar eliminates manual data entry, unifies relationship context, and orchestrates complex deal processes—without disrupting how bankers work. Backed by over two decades of CRM expertise, Navatar is used by hundreds of global firms to win more mandates, deepen coverage, and execute faster. For more information, visit Sales TeamNavatar [email protected] Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.

2 Dirt-Cheap Stocks to Buy With $1,000 Right Now
2 Dirt-Cheap Stocks to Buy With $1,000 Right Now

Yahoo

time4 hours ago

  • Yahoo

2 Dirt-Cheap Stocks to Buy With $1,000 Right Now

Written by Rajiv Nanjapla at The Motley Fool Canada Amid the expectation of rate cuts by the Federal Reserve due to easing inflation and solid second-quarter earnings, the S&P/TSX Composite Index has continued its uptrend, rising 12.9% year to date. However, the following two Canadian stocks have failed to impress investors and have lost a substantial percentage of their stock values this year. Given their discounted stock prices and healthy growth prospects, I expect these stocks to outperform over the next three years. Lightspeed Commerce Lightspeed Commerce (TSX:LSPD), which offers omnichannel commerce solutions to businesses worldwide, has been under pressure this year, with the company losing 22% of its stock value. Meanwhile, the company posted a healthy first-quarter performance of fiscal 2026 last month, beating its guidance. Its top line of $304.9 million was higher than its guidance of $285-$290 million. Year over year, its revenue grew 14.6% amid the expansion of customer locations and increased ARPU (average revenue per user). Increased software prices and growing adoption of its payments have increased its ARPU. Meanwhile, the company's net losses rose from $35 million to $49.6 million. Higher direct, general and administrative, research and development, sales and marketing, interest, and tax expenses led to an increase in its net losses. However, its adjusted EBITDA (earnings before interest, tax, depreciation, and amortization) increased by 55.9% to $15.9 million. Further, it ended the quarter with cash and cash equivalents of $447.6 million and is well-equipped to fund its growth initiatives. Amid the expanding e-commerce market, enterprises are adopting an omnichannel selling model, thereby expanding Lightspeed's addressable market. Also, the company is developing and introducing new innovative products and artificial intelligence-powered features to strengthen its position. Moreover, the company's management has reiterated its three-year guidance, with its gross profit and adjusted EBITDA projected to grow at an annualized rate of 15-18% and 35%, respectively. Therefore, the Montreal-based company's growth prospects look healthy. Further, the recent pullback in Lightspeed's stock price has dragged its NTM (next-12-month) price-to-sales multiple down to an attractive 1.4, making it an excellent buy. WELL Health Technologies Another cheap Canadian stock that I am bullish on is WELL Health Technologies (TSX:WELL), which has lost 30.3% of its stock value this year. The ongoing investigation into Circle Medical's billing practices appears to have made investors nervous, dragging its stock price down. However, it reported an excellent second-quarter performance last week with record revenue, adjusted EBITDA, and adjusted net income. Its revenue grew 57% to $356.7 million amid organic growth, acquisitions, and $40.5 million contributions from HEALWELL AI. It had over 1.7 million patient visits during the quarter, with around one million coming from Canada. The tech-enabled healthcare company's adjusted EBITDA rose 231% to $49.7 million during the quarter, while its adjusted EPS (earnings per share) came in at $0.10, representing a significant improvement from $0.02 in its previous year's quarter. Meanwhile, the growing adoption of virtual healthcare services and the digitization of clinical procedures have expanded the addressable market for WELL Health. Meanwhile, the company is developing and launching artificial intelligence-powered products to expand its customer base and strengthen its position. Additionally, the company is continuing with its inorganic expansions and has completed 14 acquisitions year to date. It has signed 15 letters of intent that can contribute $134 million to its annualized revenue. Considering its organic and inorganic growth initiatives, I believe its growth prospects look healthy. Additionally, the company currently trades at 11.3 times analysts' projected earnings for the next four quarters, which looks cheap considering its healthy growth prospects. Considering all these factors, I expect WELL Health to deliver oversized returns over the next three years. The post 2 Dirt-Cheap Stocks to Buy With $1,000 Right Now appeared first on The Motley Fool Canada. Should you invest $1,000 in Shopify right now? Before you buy stock in Shopify, consider this: The Motley Fool Stock Advisor Canada analyst team identified what they believe are the 15 best stocks for investors to buy now… and Shopify wasn't one of them. The 15 stocks that made the cut could potentially produce monster returns in the coming years. Consider MercadoLibre, which we first recommended on January 8, 2014 … if you invested $1,000 in the 'eBay of Latin America' at the time of our recommendation, you'd have $24,427.64!* Now, it's worth noting Stock Advisor Canada's total average return is 94%* – a market-crushing outperformance compared to 61%* for the S&P/TSX Composite Index. Don't miss out on our top 15 list, available when you join Stock Advisor Canada. See the 15 Stocks * Returns as of July 15th, 2025 More reading 10 Stocks Every Canadian Should Own in 2025 3 Canadian Companies Powering the AI Revolution Fool contributor Rajiv Nanjapla has no position in any of the stocks mentioned. The Motley Fool recommends Lightspeed Commerce. The Motley Fool has a disclosure policy. 2025

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store